We live in unprecedented times, with digitalisation and decoding of the human genome, combined with sufficient computational power, providing a fertile backdrop for medical innovation to aim to solve the biggest health problems facing the world in this century; including increasing and ageing population trends.
Growing companies require expert guidance and mentoring as well as adequate funding to stay focused on their strategies, exploit new opportunities and prepare for the next stage of development or exit. Investments will only be made in companies where Deepbridge either engages with or has vetted experienced professionals to work with the management team. Deepbridge will take board positions in all investee companies and takes an “active role” to guide, mentor and counsel the management team.
Through the combination of the high-quality investment management experience of the Deepbridge team, coupled with an opportunity to take advantage of the generous incentives offered through the current tax legislation, the opportunity to invest in the range of identified companies through the Deepbridge Technology Growth EIS is both timely and potentially compelling.
Andrew Hughes, Partner & Head of Renewables at Deepbridge Capital , answers some key questions regarding renewable energy.
Q. What makes renewable energy an interesting investment opportunity?
Deepbridge can confirm that the Deepbridge Technology Growth EIS and Deepbridge Life Sciences EIS currently have capacity for deployment prior to 5 April 2019, as Deepbridge Technology Growth EIS and Deepbridge Life Sciences EIS funds are usually deployed on a monthly basis. The earlier your clients funds are invested, the greater the chance that they will be invested in the current tax year.